HiTech Health
London, UK
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
76.8
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (2)
✓ MHRA GMP (5)
Quick Facts: HiTech Health
- Signal Score
- 76.8/100 (as of 2026-04-02)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- London, UK
- Modalities
- Cell Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates2 on record
MHRA GMP Certificates5 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: London, UK
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: London, UK
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: London, UK
Modalities: Cell Therapy
Capacity assessment: 53.0/100
EMA GMP Compliance 2 certificates
2023-05
2023-05
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 33517/M12614/00001 | Hitech Health Limited | Ireland | 2023-05-08 | COMPLIANT |
| 33517/IMP12686/00001 | Hitech Health Limited | Ireland | 2023-05-08 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
MHRA GMP Compliance 5 certificates
2022-08
2021-06
2021-06
2021-06
2021-06
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA 35682 Insp GMP/GDP 35682/14951420-0006[H] | FAIRVIEW HEALTH LIMITED | LONDON NW10 0AB | 2022-08-03 | COMPLIANT |
| UK MIA(IMP) 42195 Insp GMP/GDP/IMP 42195/8467466-0003[I] | PUBLIC HEALTH ENGLAND | LONDON SE1 8UG | 2021-06-28 | COMPLIANT |
| UK MIA(IMP) 14620 Insp GMP/IMP 14620/11383121-0009[I] | BARTS HEALTH NHS TRUST (PHARMACY CHEMOTHERAPY UNIT 7TH FLOOR) | LONDON EC1A 7BE | 2021-06-14 | COMPLIANT |
| UK MIA(IMP) 14620 Insp GMP/IMP 14620/291909-0014[I] | BARTS HEALTH NHS TRUST | LONDON E1 2ES | 2021-06-14 | COMPLIANT |
| UK MIA(IMP) 14620 Insp GMP/IMP 14620/15026382-0005[I] | BARTS HEALTH NHS TRUST (NUCLEAR MEDICINE RADIOPHARMACY UNIT BASEMENT) | LONDON EC1A 7BE | 2021-06-14 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
RoslinCT
Edinburgh, UK · Hopkinton, MA
Signal Score: 80.2
CAR-T, Cell Therapy, iPSC, Gene Editing
Ori Biotech
London, UK
Signal Score: 78.1
CAR-T, Cell Therapy
eXmoor Pharma
Bristol, UK
Signal Score: 78.1
Cell Therapy, AAV
Symbiosis Pharmaceutical Services
Stirling, UK
Signal Score: 76.8
Cell Therapy